ClinConnect ClinConnect Logo
Search / Trial NCT06503939

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Jul 14, 2024

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Covid 19

ClinConnect Summary

The subjects of this study were patients with chronic cough who were admitted to the Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University from September 1, 2023 to December 31, 2024. Patients are registered if they meet all of the following criteria: (1) ≥18 years of age; (2) A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough;(3) Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared; (4) Chest X-ray and/or chest CT without significant evidence of lung...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥18 years old;
  • 2. A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough;
  • 3. Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared;
  • 4. Chest X-ray and/or chest CT without significant evidence of lung disease;
  • 5. No history of chronic cough (\>8 weeks) prior to COVID-19 infection.
  • Exclusion Criteria:
  • 1. The patient refused pulmonary function and blood tests;
  • 2. The patient has previously been diagnosed with respiratory diseases with cough as one of the main symptoms, including cough variant asthma, allergic bronchitis, eosinophilic bronchitis, gastroesophageal reflux disease, chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis, interstitial lung disease, pulmonary/tracheobronchial tuberculosis, etc.;
  • 3. Patients who are pregnant or breastfeeding;
  • 4. The patient's medical records are incomplete;
  • 5. Patients lost to follow-up.

About Xiangya Hospital Of Central South University

Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.

Locations

Changsha, Hunan, China

Patients applied

0 patients applied

Trial Officials

Juan Jiang, Doctor

Principal Investigator

Xiangya Hospital of Central South University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported